Koszewski N J, Ashok S, Russell J
Department of Internal Medicine, University of Kentucky Medical Center, Lexington 40536-0084, USA.
Mol Endocrinol. 1999 Mar;13(3):455-65. doi: 10.1210/mend.13.3.0249.
1 ,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] negatively regulates expression of the avian PTH (aPTH) gene transcript, and a vitamin D response element (VDRE) near the promoter of the aPTH gene had previously been identified. The present report assessed whether the negative activity imparted by the aPTH VDRE could be converted to a positive transcriptional response through selective mutations introduced into the element. The tested sequences were derived from individual and combined mutations to 2 bp in the 3'-half of the direct repeat element, GGGTCAggaGGGTGT. Cold competition experiments using mutant and wild-type oligonucleotides in the mobility shift assay revealed minor differences in the ability of any of these sequences to compete for binding to a heterodimer complex comprised of recombinant proteins. Ethylation interference footprint analysis for each of the mutants produced unique patterns over the 3'-half-sites that were distinct from the weak, wild-type footprint. Transcriptional outcomes evaluated from a chloramphenicol acetyltransferase reporter construct utilizing the aPTH promoter found that the individual T-->A mutant produced an attenuated negative transcriptional response while the G-->C mutant resulted in a reproducibly weak positive transcriptional outcome. The double mutant, however, yielded a 4-fold increase in transcription, similar to the 7-fold increase observed from an analogous construct using the human osteocalcin VDRE. UV light crosslinking to gapped oligonucleotides assessed the polarity of heterodimer binding to the wild-type and double mutant sequences and was consistent with the vitamin D receptor preferentially binding to the 5'-half of both elements. Finally, DNA affinity chromatography was used to immobilize heterodimer complexes bound to the wild-type and double mutant sequences as bait to identify proteins that may preferentially interact with these DNA-bound heterodimers. This analysis revealed the presence of a p160 protein that specifically interacted with the heterodimer bound to the wild-type VDRE, but was absent from complexes bound to response elements associated with positive transcriptional activity. Thus, the sequence of the individual VDRE appears to play an active role in dictating transcriptional responses that may be mediated by altering the ability of a vitamin D receptor heterodimer to interact with accessory factor proteins.
1,25 - 二羟基维生素D3[1,25 - (OH)2D3]对禽甲状旁腺激素(aPTH)基因转录本的表达具有负调控作用,并且先前已在aPTH基因启动子附近鉴定出一个维生素D反应元件(VDRE)。本报告评估了通过引入到该元件中的选择性突变,aPTH VDRE赋予的负活性是否可以转化为正转录反应。测试序列来自于对直接重复元件3'-半部分中2个碱基对的单个和组合突变,即GGGTCAggaGGGTGT。在迁移率变动分析中使用突变体和野生型寡核苷酸进行的冷竞争实验表明,这些序列中任何一个竞争与由重组蛋白组成的异二聚体复合物结合的能力存在微小差异。对每个突变体的乙基化干扰足迹分析在3'-半位点上产生了独特的模式,这与微弱的野生型足迹不同。利用aPTH启动子的氯霉素乙酰转移酶报告构建体评估的转录结果发现,单个T→A突变体产生减弱的负转录反应,而G→C突变体导致可重复的微弱正转录结果。然而,双突变体使转录增加了4倍,类似于使用人骨钙素VDRE的类似构建体观察到的7倍增加。紫外线交联到缺口寡核苷酸评估了异二聚体与野生型和双突变序列结合的极性,并且与维生素D受体优先结合这两个元件的5'-半部分一致。最后,使用DNA亲和色谱法固定与野生型和双突变序列结合的异二聚体复合物作为诱饵,以鉴定可能优先与这些DNA结合的异二聚体相互作用的蛋白质。该分析揭示了一种p160蛋白的存在,其与结合到野生型VDRE的异二聚体特异性相互作用,但在与正转录活性相关的反应元件结合的复合物中不存在。因此,单个VDRE的序列似乎在决定转录反应中起积极作用,这可能是通过改变维生素D受体异二聚体与辅助因子蛋白相互作用的能力来介导的。